• Home
  • Submit news
  • Advertise with us
  • Home
  • Submit news
  • Advertise with us
Converter News
  • Converting
  • Print News
  • Food
  • Packaging
  • Manufacturing
  • Paper
  • Plastic
  • Nonwovens
Menu
  • Converting
  • Print News
  • Food
  • Packaging
  • Manufacturing
  • Paper
  • Plastic
  • Nonwovens
loading...
BREAKING NEWS
  • Manhattan Associates partners with robotics companies, automation provider and consultant
  • DOE recognizes Better Buildings Initiative partners
  • Zebra Technologies to acquire Profitect Inc.
  • Merck acquires Peloton Therapeutics for $1 billion
  • Making the Case for Lift Truck/MRO, Maintain and sustain your operations
  • IBM delivers basics of blockchain for logistics
  • Essity Divests Stake in Turkish Buisness
  • Mallinckrodt sues US health agencies after Medicaid changes
  • I.D. Images appoints two new account executives
  • Weldon Celloplast to distribute TrojanLabel equipment in India
Home Novartis MS Drug Patent Ruled Invalid

Novartis MS Drug Patent Ruled Invalid

on: April 13, 2017In:
Print Email
Three generic manufacturers win as a Federal Circuit says the patent for Novartis multiple sclerosis drug, Gilenya, is invalid.

Source: Pharma Manufacturing
More...

Share 0
Tweet
Share
Share
Share
  • Previous

    Sources Say Apple Working on Diabetes Sensors

  • Next

    One man dead in accident at ISOFlex Packaging in Nashville

Facebook